Pfizer
Executive Summary
Withdraws plans March 29 to offer up to 20% of its common stock in three separate "unbundled" financial pieces. Firm said it made decision "on the recommendation of Shearson Lehman Hutton . . . after [Pfizer] was notified by the SEC that the [unbundled stock units] would be treated as outstanding shares in determining earnings per share contrary to the advice we had received concerning precedent and current accounting standards".